Trial intelligence / Profile preview

Topical Gaseous Nitric Oxide for Venous Stasis Leg Ulcers

NCT00545298Phase 2Terminated

Sponsor
Nitric BioTherapeutics
Start
Oct 2007
Primary completion
Nov 2008
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

A Phase 2 trial of Nitric oxide patch (Fundación Cardiovascular de Colombia) in venous leg ulcer (VLU), sponsored by Nitric BioTherapeutics. Started Oct 2007; status: terminated.

02

Drugs

Nitric oxide patch (Fundación Cardiovascular de Colombia)
03

Conditions

venous leg ulcer (VLU)

Beyond the preview

Go deeper on NCT00545298.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00545298.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call